Michael L. Birnbaum, MD

Assistant Investigator, Center for Psychiatric Neuroscience, The Feinstein Institute for Medical Research

Program Director, Early Treatment Program (ETP)

Attending physician, Department of Psychiatry, Zucker Hillside Hospital and Lenox Hill Hospital

Assistant Professor, Hofstra Northwell School of Medicine

Phone: (718) 470-8305
Email: mbirnbaum@northwell.edu

About the Investigator

Dr. Birnbaum is an attending physician in the Department of Psychiatry at Lenox Hill Hospital in Manhattan and The Zucker Hillside Hospital in Glen Oaks, New York. He works as the Program Director for Northwell Health’s Early Treatment Program (ETP), a multi-site state-funded clinical and research initiative for adolescents and young adults in the early stages of psychosis. Dr. Birnbaum also serves on the board of directors for the National Alliance on Mental Illness (NAMI) NYC chapter as well as on the Advisory Board for the National Psychosis Prevention Council (NPPC).

Dr. Birnbaum has dedicated his career to improving behavioral health services, raising awareness and destigmatizing mental illness. His research interests include exploring components essential for successful early intervention, reducing the duration of untreated illness and improving engagement and patient satisfaction.

Dr. Birnbaum received his BS in Psychology and Doctor of Medicine from McGill University in Montreal, Quebec. He then went on to become Chief Resident and complete his Child and Adolescent psychiatry fellowship in the Department of Psychiatry at Mt. Sinai-St. Luke’s-Roosevelt Hospital.

Research Focus

My research to date has focused primarily on psychotic disorders with an emphasis on the early stages of illness and first-episode schizophrenia. I have explored components essential for the development of successful early intervention services, reducing the duration of untreated psychosis, and improving engagement and long-term functional outcomes.

I am currently a Co-Investigator of an NIMH funded R34 study (MH103835) entitled “Developing Strategies to Reduce Duration of Untreated Psychosis in the Age of Social Media and the Internet.” This study aims to harness social media and other online platforms as a means of improving identification and engagement of adolescents with psychotic disorders. I am additionally exploring the potential benefits of selective serotonin reuptake inhibitors (SSRI) in delaying or preventing the onset of psychosis.

Lab Members

Asra Rizvi, MA
Asst. Research Coordinator
Phone: (718) 470-5352
Email: arizvi3@northwell.edu


McGill University, Montreal, Canada
Degree: BSc
Filed of Study: Psychology

McGill University, Montreal, Canada
Degree: MDCM
Field of Study: Medicine

Mt. Sinai – St. Luke’s Hospital Center, NYC, NY
Filed of Study: Psychiatry Residency

Mt. Sinai – St. Luke’s Hospital Center, NYC, NY
Field of Study: Child and Adolescent Psychiatry Fellowship

Awards and Honors

2014 Schizophrenia International Research Society Travel Award
2013-2014 American Academy of Child and Adolescent Psychiatry (AACAP) Junior Investigator’s Award
2013 Japanese Society of Psychiatry and Neurology Fellowship and Travel Award
2012-2013 Associate Trustees Research Award
2011-2013 Van Ameringen Foundation Award

  1. Birnbaum ML, Sharif Z. “Medication Adherence in Schizophrenia: Patient Perspectives and the Clinical Utility of Paliperidone ER.” Patient Preference and Adherence. 2008; 2:233-240.
  2. Birnbaum ML, Saito E, Gerhard T, Winterstein A, Olfson M, Correll CU. “Pharmacoepidemiology of Second-Generation Antipsychotic Use for ADHD: Trends and Implications for Clinicians.” Current Psychiatry Reports.2013; 15:382-395.
  3. Birnbaum ML, Pascucci O, Libby I, Candan K, Kane JM. “The Impact of Online Resources and Social Media on Help Seeking Behavior in Youth with Psychotic Symptoms.” Early Intervention in Psychiatry. 2014; e-pub.
  4. Birnbaum ML, Rizvi A, Correll C, Kane JM. “The Role of Social Media and the Internet in Pathways to Care for Adolescents and Young Adults with Psychotic Disorders and Non-Psychotic Mood Disorders.” Early Intervention in Psychiatry. In Press.
  5. Ben-David S, Birnbaum ML, Eilenberg E, DeVylder JE, Gill K, Schienle J, Azimov N, Lukens E, Davidson L, Corcoran C. “The Subjective Experience of Youths at Clinical High Risk for Psychosis: A Qualitative Research Study.” Psychiatric Services. 2014; e-pub.
  6. Grudnikoff E, Soto E, Frederickson A, Birnbaum ML, Saito E, Dicker R, Kane J, Correll C,. “Suicidality and Hospitalization as Cause and Outcome of Pediatric Psychiatric Emergency Room Visits.” Eur Child Adolesc Psychiatry. 2014; e-pub.
  7. Gerstenberg M, Hauser M, Al-Jadiri A, Sheridan E, Kishimoto T, Borenstein Y, Vernal D, David L, Saito E, Carella M, Singh S, Carbon M, Fernández-Jiménez S, Birnbaum ML, Auther A, Carrión R, Cornblatt B, Kane JM, Walitza S, Correll C. “Frequency and Correlates of DSM-5 Attenuated Psychosis Syndrome in Adolescent Inpatients with Mixed Non-Psychotic Diagnoses.” J Clin Psychiatry– In Press.

View more at PubMed